Table of contents

ORIGINAL ARTICLE

• Alteration of cell-cycle regulation in epithelial ovarian cancer (1 October, 2008)

  E. J. Nam, Y. T. Kim
• Long-term adjustment of early-stage ovarian cancer survivors (1 October, 2008)

  U. A. Matulonis, A. Kornblith, H. Lee, J. Bryan, C. Gibson, C. Wells, J. Lee, L. Sullivan, R. Penson
• Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer (1 October, 2008)

  T. T. Nguyen, J. D. Wright, M. A. Powell, R. K. Gibb, J. S. Rader, J. E. Allsworth, D. G. Mutch
• Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus (1 October, 2008)

  P. J. Hoskins, N. Le
• Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety (1 October, 2008)

  J.-Y. Park, J. Bae, M. C. Lim, S. Y. Lim, S.-S. Seo, S. Kang, S.-Y. Park
• Combination chemotherapy of intraperitoneal carboplatin and intravenous paclitaxel in suboptimally debulked epithelial ovarian cancer (1 October, 2008)

  S. Nagao, K. Fujiwara, R. Ohishi, Y. Nakanishi, N. Iwasa, M. Shimizu, T. Goto, K. Shimoya
• A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma (1 October, 2008)

  B. Györffy, M. Dietel, T. Fekete, H. Lage
• Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas (1 October, 2008)

  M. M.M. Woo, C. M. Salamanca, M. Miller, J. Symowicz, P. C.K. Leung, C. Oliveira, T. G. Ehlen, C. B. Gilks, D. Huntsman, N. Auersperg
• cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation (1 October, 2008)

  N. M. Linnerth, J. B. Greenaway, J. J. Petrik, R. A. Moorehead
• High-intensity electric pulses induce mitochondria-dependent apoptosis in ovarian cancer xenograft mice (1 October, 2008)

  C. Li, L.-N. Hu, X.-J. Dong, C.-X. Sun, Y. Mi
• Claudin-7 expression in human epithelial ovarian cancer (1 October, 2008)

  R. A. Tassi, E. Bignotti, M. Falchetti, M. Ravanini, S. Calza, A. Ravaggi, E. Bandiera, F. Facchetti, S. Pecorelli, A. D. Santin
• Total tissue lactate dehydrogenase activity in endometrial carcinoma (1 October, 2008)

  Š. ŠIMAGA, M. Abramić, M. Osmak, D. Babić, J. Ilić-Forko
• The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients (1 October, 2008)

  B. Kotowicz, M. Fuksiewicz, M. Kowalska, J. Jonska-Gmyrek, M. Bidzinski, J. Kaminska
• Endocervical adenocarcinoma associated with lobular endocervical glandular hyperplasia showing rapid reaccumulation of hydrometra (1 October, 2008)

  K. Takeuchi, T. Tsujino, M. Sugimoto, S. Yoshida, S. Kitazawa
• The impact of microinvasive cancer of the cervix on women during follow-up (1 October, 2008)

  M. Cairns, N. M. Gray, M. E. Cruickshank
• Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery (1 October, 2008)

  I. L. Atahan, E. Ozyar, F. Yildiz, G. Ozyigit, M. Genc, S. Ulger, A. Usubutun, F. KÖSE, K. Yuce, A. Ayhan
• Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix (1 October, 2008)

  J. Kodama, M. Takemoto, N. Seki, K. Nakamura, A. Hongo, S. Moriya, S. Kanazawa, Y. Hiramatsu
• Serial histologic observation of endometrial adenocarcinoma treated with high-dose progestin until complete disappearance of carcinomatous foci-review of more than 25 biopsies from five patients (1 October, 2008)

  S. Kamoi, Y. Ohaki, O. Mori, K. Kurose, M. Fukunaga, T. Takeshita
• Laparoscopically assisted versus open surgery for endometrial cancer—a meta-analysis of randomized controlled trials (1 October, 2008)

  F. Lin, Q. J. Zhang, F. Y. Zheng, H. Q. Zhao, Q. Q. Zeng, M. H. Zheng, H. Y. Zhu
• Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study (1 October, 2008)

  F LÉCURU, M. A Le Frère Belda, A. S Bats, L Tulpin, U Metzger, S Olschwang, P Laurent-Puig
• Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients (1 October, 2008)

  J.-Y. Park, E. N. Kim, D.-Y. Kim, J.-H. Kim, Y.-M. Kim, Y.-T. Kim, J.-H. Nam
• Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma

  (1 October, 2008)

  S. Kang, S. S. Seo, H. J. Chang, C. W. Yoo, S. Y. Park, S. M. Dong
• Serous carcinoma of the uterus—determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation

  (1 October, 2008)

  P. Singh, C. L. Smith, G. Cheetham, T. J. Dodd, M. L.J. Davy
• Expression of pituitary tumor-transforming gene in endometrial cancer as a prognostic marker (1 October, 2008)

  J. W. Kim, J. Y. Song, J. M. Lee, J. K. Lee, N. W. Lee, B. W. Yeom, K. W. Lee
• Primary fallopian tube carcinoma associated with ovulation induction; a case report (1 October, 2008)

  A. Deliveliotou, D. Hassiakos, S. Fotiou, E. Karvouni, G. Creatsas